At the Envision Summit 2025 in San Juan, Puerto Rico, Deepak Sambhara, MD, gave insight into the 96-week post hoc fluid ...

Researchers sought to determine the prognostic value of home vs office measured pulse rate in patients with hypertension.

Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics ...

RSV infection that is managed via primary care in children under 5 years of age leads to a substantial burden for families, primary care resources, and society.

Compared with placebo, zavegepant nasal spray yielded sustained relief of acute pain and function in migraine.

Mepolizumab reduces asthma exacerbations among real-world patients with severe asthma and an eosinophilic phenotype.

The following is a summary of “Association of Year-to-Year Lipid Variability with Risk of Cognitive Decline and Dementia in ...

Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced ...

AlgoTherapeutix announces results of its phase 2 “ACT” trial of ATX01 in chemotherapy-induced peripheral neuropathy: Paris, France Wednesday, February 19, 2025, 13:00 Hrs [IST ...

Low-dose methotrexate was not clinically effective for lowering blood pressure among patients without rheumatic disease who have cardiovascular risk factors.

The phase 3 NIAGARA trial randomised 1,063 MIBC patients to receive Imfinzi plus neoadjuvant chemotherapy prior to bladder ...